Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 396 of 6351
-
New drug cocktail aims to boost head and neck cancer surgery success
Disease control Recruiting nowA multicenter, randomized, double-blind, phase II clinical study designed to evaluate the safety, pharmacokinetics, and preliminary efficacy of Becotatug Vedotin for Injection in combination with PD-1 in patients with locally advanced resectable head and neck squamous cell carcin…
Phase 2 • Sponsor: Lepu Biopharma Co., Ltd. • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
A Needle-Free heart check? MRI may replace invasive catheterization
Diagnosis By invitation onlyThis study evaluates whether new flow parameters of the cardiac magnetic resonance imaging (MRI) allow evaluation of parameters for which usually invasive rigth-left heart catheterization are necessary. Patients who require a right-left heart catheterization will undergo the same…
Sponsor: Tobias Rutz • Aim: Diagnosis
Last updated Aug 05, 2026 00:00 UTC
-
Probiotic pill aims to stop recurrent cystitis without antibiotics
Prevention Not yet recruitingRecurrent cystitis is a common condition in menopausal women and is associated with impaired quality of life and increased antibiotic use. This randomized, double-blind, placebo-controlled clinical trial aims to evaluate the efficacy and safety of Colipral® in preventing recurren…
Sponsor: Liaquat University of Medical & Health Sciences • Aim: Prevention
Last updated Jul 08, 2026 00:00 UTC
-
Could thousands of women skip hormone therapy after breast cancer?
Disease control Recruiting nowThe goal of this clinical trial is to determine whether a selected population of women with early-stage, low-risk breast cancer can avoid hormone therapy without increasing their risk of relapse. It will also evaluate the prognosis of these participants compared to participants w…
Phase 2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Lifestyle makeover could slash Alzheimer's risk in genetically vulnerable seniors
Prevention Not yet recruitingWellderly Brain is a randomized, direct-to-participant trial evaluating whether a virtually delivered, multidomain lifestyle coaching intervention can favorably impact plasma biomarkers of Alzheimer's disease (AD) in adults aged 60-80 with APOE4 positivity or elevated polygenic r…
Sponsor: Scripps Translational Science Institute • Aim: Prevention
Last updated Jun 27, 2026 13:06 UTC
-
New hope for young leukemia patients: experimental drug combo targets resistant cancer
Disease control Recruiting nowMulti-center, open-label, single arm study of asciminib in participants aged ≥1 year to ≤30 years old with r/r Ph+ or ABL-class Ph-like ALL. This study will have 2 parts: Part 1 dose escalation and Part 2 dose expansion. Part 1 dose escalation will enroll participants aged ≥1 yea…
Phase 1/2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Can specialized exercises improve balance in children with obesity?
Disease control Recruiting nowIntroduction: Childhood obesity can impair postural control, balance, and motor skills, thereby limiting participation in physical activity. Aerobic exercise is widely used to improve cardiovascular fitness and support weight management in children with obesity. In recent years, …
Sponsor: Istanbul University - Cerrahpasa • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Laser and AI team up to spot lung cancer in minutes during surgery
Diagnosis Recruiting nowThis study aims to evaluate whether femtosecond laser imaging combined with FastLung AI model can provide intraoperative diagnostic performance that is non-inferior to standard frozen section diagnosis for pulmonary nodules or suspected pulmonary tumor lesions. Patients scheduled…
Sponsor: Shanghai Chest Hospital • Aim: Diagnosis
Last updated Sep 06, 2026 00:00 UTC
-
Targeted antibody may boost brain cancer treatment after incomplete surgery
Disease control Not yet recruitingThis is a prospective, single-arm study. The study population consists of adult patients with a confirmed diagnosis of EGFR-positive high-grade glioma who have radiographic residual tumor following surgical resection. Participants will receive nimotuzumab in combination with the …
Phase 2 • Sponsor: Tianjin First Central Hospital • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Extra ablation target may cut AF recurrence in persistent cases
Disease control By invitation onlyTo date, no optimal treatment has been established to improve outcomes in patients with persistent atrial fibrillation. The safety and efficacy of pulsed-field ablation (PFA) have been demonstrated in several studies, and its clinical application is expanding. \- In patients wit…
Sponsor: Ewha Womans University Mokdong Hospital • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Magic mushroom therapy gets a monitor: new trial for stubborn depression
Symptom relief Recruiting nowPsilocybin, the chemical component of "magic mushrooms", has been administered with psychological support in several randomized clinical trials (RCTs) showing large and sustained antidepressant effects. The purpose of this study is to determine the role of psilocybin monitors on…
Phase 2 • Sponsor: Centre for Addiction and Mental Health • Aim: Symptom relief
Last updated Aug 23, 2026 00:00 UTC
-
New shot aims to help kids with rare heart-muscle disease move easier
Disease control Recruiting nowPhase 3b/4, randomized, double-blind, parallel-group, placebo-controlled clinical trial to evaluate the efficacy, safety, and pharmacokinetics of a once daily SC injection of elamipretide in subjects with genetically confirmed BTHS for 72 weeks. The primary trial objective is to …
Phase 4 • Sponsor: Stealth BioTherapeutics Inc. • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New hope for rare lung cancer: experimental drug combo enters human trials
Disease control Recruiting nowThis study is being done to learn more about a new medicine called PF-08634404. The study team wants to understand how well PF-08634404 works when given alone or with chemotherapy . Chemotherapy is a type of cancer treatment that uses medicines to destroy cancer cells or stop the…
Phase 2 • Sponsor: Pfizer • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New hope for tough lung cancer: ABBV-706 faces off against standard care
Disease control Recruiting nowSmall cell lung cancer (SCLC) is characterized by aggressive and rapid growth and a tendency to develop early spread to distant sites including mediastinal lymph nodes, liver, bones, adrenal glands, and brain. The purpose of this study is to assess safety, tolerability, and chang…
Phase 3 • Sponsor: AbbVie • Aim: Disease control
Last updated Sep 10, 2026 03:00 UTC
-
Viruses that eat bacteria could help save infected joint replacements
Disease control Not yet recruitingTotal joint replacement (TJR) has revolutionized care provided for patients suffering from disabling joint pain. Unfortunately, periprosthetic joint infection (PJI) remains a devastating complication and the leading cause of failure after TJR. Current standard treatment for PJI r…
Phase 2/3 • Sponsor: Ottawa Hospital Research Institute • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Targeted radiation zaps childhood brain tumors in early trial
Disease control Recruiting nowThe purpose of this study is to find out whether 177Lu-DPTA-omburtamab is a safe treatment for children and adolescents with recurrent/refractory medulloblastoma or another type of cancer with CNS metastases.
Phase 1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Cream-and-Steroid combo aims to recolor vitiligo patches
Disease control Recruiting nowThis study is a prospective, multicenter, real-world observational study to assess the clinical efficacy and safety of topical 1.5% Ruxolitinib phosphate cream used in combination with systemic corticosteroids in a real-world clinical setting. The study plans to observe patients …
Sponsor: ShanShan Li • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New 'Smart' immune cells take on kidney cancer in early trial
Disease control Recruiting nowThere are 2 parts to this clinical research study: Part 1 (Dose Escalation) and Part 2 (Dose Expansion). The goal of Part 1 is to find the recommended dose of LNK001 in patients with advanced or metastatic ccRCC. The goal of Part 2 is to learn if the recommended dose of LNK001 …
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Patient feedback after surgery may cut opioid misuse by half
Disease control Not yet recruitingThe OPTIMISTE program is based on a structured postoperative follow-up centered on patients' subjective perception of recovery using validated Patient Reported Outcome Measures (PROMs), including the mQoR-15f score. Follow-up is delivered by specifically trained nurses and embedd…
Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New hope for immunotherapy side effects: blood filtering may replace steroids
Disease control Not yet recruitingExtracorporeal photopheresis (ECP) is an immunomodulatory therapy in which the photoactivating agent methoxsalen (also known as UVADEX) is used in combination with ultraviolet A (UVA) light. Immune checkpoint inhibitor therapy is widely used for the treatment of several cancers,…
Phase 2 • Sponsor: Therakos LLC • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC